Should You Buy Hims & Hers Stock on the Dip?
Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach. Read More: Earn ...
Hims & Hers: Revolutionizing Telehealth And Captivating Investors - Here's Why You Should Buy
Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...
Amazon Gets Into the Boner Pill Business, Hims Stock Goes Limp
Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...
Hims & Hers Stock Climbs After Former Regulator Autor Joins Board
Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board. The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled ...
Business Insider1d
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Celcuity (CELC)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS – Research Report) and Celcuity (CELC – Research Report). Don't Miss our Black ...
Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...
Amazon's push into telehealth knocks shares of Hims & Hers
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...
Hims & Hers Health: The Amazon Curse Is Being Overstated
Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...
Hims & Hers Health首席商务官出售价值16.5万美元股票
旧金山——根据向美国证券交易委员会提交的监管文件，Hims & Hers Health, Inc. (NYSE:HIMS)的首席商务官Michael Chi最近出售了公司股票，价值约16.5万美元。 根据10b5-1交易计划执行的这笔交易涉及以每股22.00美元的价格出售7,500股A类普通股。此次出售后，Chi的直接持股减少至183,980股。
Hims & Hers健康公司首席会计官出售价值9,166美元的股票
旧金山——根据最近的SEC文件，Hims & Hers Health Inc. (NYSE:HIMS)的首席会计官Becklund Irene于2024年11月18日执行了一系列股票交易。 Irene行权获得472股A类普通股，每股价格为9.41美元。随后，她以每股19.42美元的价格出售了相同数量的股票，总销售价值为9,166美元。这些交易是根据2023年9月11日采用的预先安排的交易计划进行的 ...